The India Bizz Startup News Website
DirectoryIPO Company
IPO COMPANYFeatured

Lord’s Mark Industries Ltd

Listed Company BSE Limited

Desk Verified Journalist Discover the latest startup, business, and funding news. Get insights on trends, IPOs, mergers, and acquisitions. Perfect for entrepreneurs, investors. Startup Expert Business Media 2737 Articles

LiveListed through NCLT-approved Resolution Plan / Reverse MergerBSE Group XT / Trade-to-TradeISIN INE567L01025
Current price₹85.16 BSE Limited
Current Price85.16Latest available
Market Cap3,633 Cr
EPS1.14
ROE10.4%
Face Value₹10 per equity share
01
COMPANY

Business overview

Lord's Mark Industries Limited is a diversified Indian business group with operations focused primarily on Healthcare & Diagnostics, MedTech, Renewable Energy, LED and Solar solutions.

Its healthcare operations include diagnostic products, IVD products, rapid testing kits, laboratory equipment, MedTech solutions, renal-care technologies and surgical products.

The company also operates in LED and solar solutions, including smart lighting, solar street lighting, rooftop solar, solar home lighting and renewable-energy infrastructure projects.

The company's business model spans B2G, B2B and B2C markets, with government and public-sector engagements forming an important part of its operating ecosystem

INDUSTRY

Lord's Mark operates across several large and expanding Indian markets:

Healthcare & Diagnostics

Growing demand for affordable diagnostics, preventive healthcare, IVD products, pathology infrastructure and point-of-care testing.

MedTech

India's increasing focus on domestic medical-device manufacturing, healthcare technology, remote monitoring and indigenous medical innovation creates opportunities for MedTech companies.

Renewable Energy & Solar

Government-led renewable-energy programmes, rural electrification, rooftop solar adoption and clean-energy infrastructure are supporting long-term demand.

Smart Lighting

Smart-city development, energy efficiency, municipal infrastructure and rural electrification provide opportunities for LED and solar lighting providers.

02
OFFER / LISTING

IPO details

IPO StatusLive
IPO TypeListed through NCLT-approved Resolution Plan / Reverse Merger
Issue SizeN/A – No conventional IPO
Fresh IssueNA
Offer for SaleNA
Price BandNA
Issue PriceNA
Lot Size1 share
Minimum Investment₹10 based on face value; actual market investment depends on prevailing market price
Listing Date10 July 2026
ExchangeBSE Limited
Listing SegmentBSE Group XT / Trade-to-Trade
Face Value₹10 per equity share
RegistrarPurva Sharegistry (India) Pvt. Ltd.
Lead ManagersNavigant Corporate Advisors Limited
03
FUNDAMENTALS

Financial performance

Revenue685 Cr
EBITDA85 Cr
PAT / Net Profit49 Cr
EPS1.14
Total Assets1,443 Cr
Total Debt384 Cr
ROE10.4%

Financial figures are displayed as provided in the profile data and should be read with the stated reporting period and source documents.

04
OWNERSHIP

Shareholding & subscription

Promoter Holding — Pre IPOSachidanand H. Upadhyay individually held approximately 77.54%, according to the latest available shareholding data.
Shares Offered42,65,96,719
Pre-Issue Shares10,00,000
Post-Issue Shares42,66,22,217
05
INTELLIGENCE

Business & investment view

Competitive strengths

Diversified exposure across healthcare and renewable-energy markets
Established government and institutional relationships
Diagnostics and IVD product portfolio
MedTech development partnerships
Manufacturing and OEM capabilities
LED and solar project execution experience
Presence across B2G, B2B and B2C markets
Long operating history
Growing international ambitions
Technology and R&D focus

The company states that it has more than 30 registered diagnostic brands and operates ISO 13485:2016 and CE-certified diagnostic capabilities. It also highlights collaborations involving IIT Bombay and BARC in MedTech development.

Growth strategy

Lord's Mark's stated roadmap includes:

Expansion of MedTech manufacturing
Development of an independent R&D capability in India
Expansion into international markets
OEM manufacturing
Healthcare and diagnostics expansion
Solar module manufacturing
Electronics manufacturing for MedTech
Expansion of renewable-energy projects
Strategic partnerships and acquisitions
Development of global subsidiaries and business platforms

The company's roadmap targets a global footprint and significantly larger business scale over the coming years.

Key risks

High Receivable Days

1.Screener reports elevated debtor days, which can create working-capital pressure.

2. High Promoter Ownership

Promoter ownership is approximately 79.84%, resulting in relatively lower public ownership.

3. Diversified Business Model

Operating across healthcare, MedTech, LED, solar and other activities creates execution and capital-allocation complexity.

4. Execution Risk

Future growth depends on successful execution of large healthcare, MedTech and renewable-energy projects.

5. Regulatory Risk

Healthcare, diagnostics and medical-device businesses are subject to regulatory approvals and compliance requirements.

6. Debt & Working Capital

The company has borrowings and substantial working-capital requirements, making cash-flow management important.

7. Trading / Liquidity Risk

The company's shares trade in the BSE XT / Trade-to-Trade segment, which can affect trading flexibility and liquidity.